Get comprehensive CYP2C9 Gene Coumarin/Warfarin Resistance DNA testing for $500 USD. Advanced NGS technology detects genetic variants affecting blood thinner medication response. Available in New York
Get the HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test for only $200 in USA. This genetic test helps prevent severe skin reactions to epilepsy medications. Available in New York HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test Original price was: $300.Current price is: $200.
Get the CYP2B6 Gene Efavirenz Poor Metabolism NGS Genetic DNA Test for only $500 USD in USA. Discover your genetic response to HIV medication Efavirenz with next-generation sequencing technology. Available in New York CYP2B6 Gene Efavirenz Poor Metabolism Genetic Test Original price was: $700.Current price is: $500.
Sale!

CYP2C9 Gene Coumarin/Warfarin Resistance Due to CYP2C9 Variants Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CYP2C9 Gene Coumarin/Warfarin Resistance DNA Test is a cutting-edge genetic analysis that identifies specific CYP2C9 gene variants affecting how individuals metabolize coumarin-based anticoagulants like warfarin. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that can lead to either resistance or increased sensitivity to these critical blood-thinning medications. Understanding your CYP2C9 genetic profile helps healthcare providers determine optimal warfarin dosing, reducing the risk of bleeding complications or treatment failure. The test is particularly valuable for patients requiring long-term anticoagulation therapy, those with unusual warfarin response patterns, or individuals with family histories of medication resistance. Results provide actionable insights for personalized medication management, potentially preventing serious adverse events. Available for $500 USD, this test represents a significant advancement in precision medicine for cardiovascular care and anticoagulation therapy optimization.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CYP2C9 Gene Coumarin/Warfarin Resistance Due to CYP2C9 Variants NGS Genetic DNA Test

Understanding CYP2C9 Genetic Testing for Warfarin Response

The CYP2C9 Gene Coumarin/Warfarin Resistance DNA Test represents a breakthrough in personalized medicine, specifically designed to optimize anticoagulation therapy for patients requiring blood-thinning medications. This advanced genetic analysis examines variations in the CYP2C9 gene, which plays a crucial role in metabolizing coumarin-based anticoagulants like warfarin.

What Does This Test Measure?

This comprehensive NGS-based genetic test specifically detects:

  • Common CYP2C9 gene variants (*2, *3, *5, *6, *8, *11) that affect warfarin metabolism
  • Genetic polymorphisms influencing enzyme activity and drug clearance rates
  • Specific mutations associated with warfarin resistance or hypersensitivity
  • Genetic markers that predict individual response to anticoagulation therapy

Who Should Consider CYP2C9 Genetic Testing?

This test is particularly recommended for individuals experiencing:

  • Unusual warfarin response requiring unusually high or low doses
  • Difficulty achieving stable INR levels despite standard dosing
  • History of bleeding complications while on warfarin therapy
  • Family history of warfarin resistance or sensitivity
  • Planned initiation of long-term anticoagulation therapy
  • Recurrent thrombosis despite adequate anticoagulation

Clinical Benefits of CYP2C9 Genetic Testing

Understanding your CYP2C9 genetic profile offers numerous clinical advantages:

  • Personalized Dosing: Enables precise warfarin dosing based on genetic metabolism capacity
  • Reduced Complications: Minimizes risk of bleeding events and thrombotic complications
  • Faster Stabilization: Accelerates achievement of therapeutic INR levels
  • Improved Safety: Enhances medication safety profile through genetic-guided prescribing
  • Cost-Effective Care: Reduces hospitalizations and emergency visits related to dosing issues

Understanding Your Test Results

Your CYP2C9 genetic test results will provide clear guidance on warfarin metabolism:

  • Normal Metabolizer: Standard warfarin dosing typically effective
  • Intermediate Metabolizer: May require lower warfarin doses and closer monitoring
  • Poor Metabolizer: Significantly reduced warfarin clearance, requiring substantially lower doses
  • Rapid Metabolizer: May require higher warfarin doses to achieve therapeutic effect

All results include detailed interpretation and specific dosing recommendations for your healthcare provider.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have comprehensive testing facilities across the United States, including major metropolitan areas:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston and Texas facilities
  • Phoenix and Southwest centers
  • And numerous additional locations nationwide

Take Control of Your Anticoagulation Therapy

Don’t leave your warfarin response to chance. Our CYP2C9 genetic testing provides the scientific foundation for safer, more effective anticoagulation management. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.

Ready to optimize your medication therapy? Book your CYP2C9 genetic test today by calling +1(267) 388-9828 or scheduling online through our secure patient portal.

SKU: 3646 Category:

Related products